Literature DB >> 18074002

Ethnic differences in low-density lipoprotein particle size in hypertensive adults.

Iftikhar J Kullo1, M Fuad Jan, Kent R Bailey, Thomas H Mosley, Stephen T Turner.   

Abstract

BACKGROUND: Hypertensive African Americans have higher rates of coronary heart disease (CHD) than their non-Hispanic white counterparts despite having higher HDL cholesterol (HDL-C) levels and lower triglyceride levels.
OBJECTIVE: The goal of the present study was to assess whether low-density lipoprotein (LDL) particle size, a correlate of the above lipid traits and a risk factor for CHD, differs between hypertensive African Americans and whites.
METHODS: Participants included 1177 hypertensive African Americans from Jackson MS (60+/-7 years, 72.4% women) and 860 hypertensive whites from Rochester MN (58+/-7 years, 56.7% women). LDL particle size was measured by polyacrylamide gradient gel electrophoresis. Within each sex, we assessed whether ethnicity was significantly associated with differences in LDL particle size after adjustment for CHD risk factors (age, total cholesterol, HDL-C, triglycerides, systolic BP, diabetes, history of smoking, body mass index), statin use, and estrogen use (in women), and "lifestyle" variables (physical activity and alcohol intake).
RESULTS: Although HDL-C levels were higher and triglyceride levels lower in African Americans, LDL particle size (adjusted for CHD risk factors) was lower (P < 0.0001) in African American men and women than in their white counterparts (mean +/- SD; men, 267.6+/-5.2 A vs. 270.2+/-4.8 A; women 268.7+/-5.1 A vs. 271.3+/-5.1 A). In both sexes, African American ethnicity was associated with lower LDL particle size after adjustment for CHD risk factors, statin use and estrogen use (in women), as well as physical activity and alcohol intake.
CONCLUSION: Hypertensive African American men and women have lower LDL particle size than their white counterparts despite having higher HDL-C and lower triglycerides.

Entities:  

Keywords:  LDL particle size; ethnicity; hypertension; low-density lipoprotein; risk factors

Year:  2007        PMID: 18074002      PMCID: PMC2130773          DOI: 10.1016/j.jacl.2007.05.001

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  32 in total

1.  Black-white differences in serum lipids and lipoproteins in Evans County.

Authors:  H A Tyroler; C G Hames; I Krishan; S Heyden; G Cooper; J C Cassel
Journal:  Prev Med       Date:  1975-12       Impact factor: 4.018

2.  Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement.

Authors:  J D Otvos; E J Jeyarajah; D W Bennett; R M Krauss
Journal:  Clin Chem       Date:  1992-09       Impact factor: 8.327

3.  Can the clinical efficacy of the HMG CoA reductase inhibitors be explained solely by their effects on LDL-cholesterol?

Authors:  A Gaw
Journal:  Atherosclerosis       Date:  1996-09-06       Impact factor: 5.162

4.  Putting low-density lipoproteins at center stage in atherogenesis.

Authors:  A D Sniderman; T Pedersen; J Kjekshus
Journal:  Am J Cardiol       Date:  1997-01-01       Impact factor: 2.778

5.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.

Authors:  M J Stampfer; R M Krauss; J Ma; P J Blanche; L G Holl; F M Sacks; C H Hennekens
Journal:  JAMA       Date:  1996-09-18       Impact factor: 56.272

6.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield
Journal:  Arch Intern Med       Date:  2003-02-24

7.  Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study.

Authors:  Johanna L Johnson; Cris A Slentz; Brian D Duscha; Gregory P Samsa; Jennifer S McCartney; Joseph A Houmard; William E Kraus
Journal:  Atherosclerosis       Date:  2004-10       Impact factor: 5.162

8.  Identification of multiple subclasses of plasma low density lipoproteins in normal humans.

Authors:  R M Krauss; D J Burke
Journal:  J Lipid Res       Date:  1982-01       Impact factor: 5.922

9.  Factor analysis and defining the metabolic syndrome.

Authors:  Earl S Ford
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

10.  Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991.

Authors:  R J Kuczmarski; K M Flegal; S M Campbell; C L Johnson
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

View more
  5 in total

1.  Association of serum lipids with outcomes in Hispanic hemodialysis patients of the West versus East Coasts of the United States.

Authors:  Hamid Moradi; Pouya Abhari; Elani Streja; Moti L Kashyap; Gaurang Shah; Daniel Gillen; Madeleine V Pahl; Nosratola D Vaziri; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2015-05-30       Impact factor: 3.754

2.  Physical Activity Is Associated With Reduced Left Ventricular Mass in Obese and Hypertensive African Americans.

Authors:  Daisuke Kamimura; Paul D Loprinzi; Wanmei Wang; Takeki Suzuki; Kenneth R Butler; Thomas H Mosley; Michael E Hall
Journal:  Am J Hypertens       Date:  2017-06-01       Impact factor: 2.689

Review 3.  Managing mixed dyslipidemia in special populations.

Authors:  Michael Miller
Journal:  Prev Cardiol       Date:  2010

4.  Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity.

Authors:  Alexis C Frazier-Wood; Ani Manichaikul; Stella Aslibekyan; Ingrid B Borecki; David C Goff; Paul N Hopkins; Chao-Qiang Lai; Jose M Ordovas; Wendy S Post; Stephen S Rich; Michèle M Sale; David Siscovick; Robert J Straka; Hemant K Tiwari; Michael Y Tsai; Jerome I Rotter; Donna K Arnett
Journal:  Hum Genet       Date:  2012-12-22       Impact factor: 4.132

5.  Optimal serum cholesterol concentrations are associated with accelerated bone loss in African ancestry men.

Authors:  A L Kuipers; I Miljkovic; R Evans; C H Bunker; A L Patrick; J M Zmuda
Journal:  Osteoporos Int       Date:  2015-11-24       Impact factor: 4.507

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.